Evidence map›Paper›PMID 34634485›Full record

ArticleInfectious diseases now2022

Evolution of baseline characteristics and severe outcomes in COVID-19 inpatients during the first and second waves in Northeastern France.

M Martinot, M Eyriey, S Gravier, D Kayser, C Ion, M Mohseni-Zadeh, J C Ongagna, A Schieber, C Kempf, Centre Alsace Study Group

Abstract read
In one paragraph

Article in Infectious diseases now, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. [COVID 19 - Hospital Admission in the First and Second Wave in Germany].Deutsche medizinische Wochenschrift (1946) · 2023
    Article
  5. Observational
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

M MartinotInfectious Diseases Department, Hôpitaux Civils de Colmar, 39, avenue de la Liberté, 68024 Colmar cedex, France. Electronic address: martin.martinot@ch-colmar.fr.
M EyrieyClinical Research Department, Hôpitaux Civils de Colmar, Colmar, France.
S GravierInfectious Diseases Department, Hôpitaux Civils de Colmar, 39, avenue de la Liberté, 68024 Colmar cedex, France.
D KayserInfectious Diseases Department, Hôpitaux Civils de Colmar, 39, avenue de la Liberté, 68024 Colmar cedex, France.
C IonInfectious Diseases Department, Hôpitaux Civils de Colmar, 39, avenue de la Liberté, 68024 Colmar cedex, France.
M Mohseni-ZadehInfectious Diseases Department, Hôpitaux Civils de Colmar, 39, avenue de la Liberté, 68024 Colmar cedex, France.
J C OngagnaClinical Research Department, Hôpitaux Civils de Colmar, Colmar, France.
A SchieberClinical Research Department, Hôpitaux Civils de Colmar, Colmar, France.
C KempfClinical Research Department, Hôpitaux Civils de Colmar, Colmar, France.
Centre Alsace Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTwo COVID-19 epidemic waves occurred in France in 2020. This single-center retrospective study compared patients' characteristics and outcomes. PATIENTS AND

methodsWe included all patients with confirmed COVID-19 admitted to Colmar Hospital in March (n=600) and October/November (n=205) 2020.

resultsMedian ages, sex ratio, body mass index, and number of comorbidities were similar in wave 1 and 2 patients. Significant differences were found for temperature (38°C vs. 37.2), need for oxygen (38.6% vs. 26.8%), high-flow cannula (0% vs. 8.3%), and steroid use (6.3% vs. 54.1%). Intensive care unit (ICU) hospitalizations (25.5% vs. 15.1%, OR: 0.44, 95% CI [0.28; 0.68], P=0.002) and deaths (19.2% vs. 12.7%, OR: 0.61, 95% CI [0.37; 0.98], P=0.04) decreased during the second wave. Except for cardiovascular events (5.5% vs. 10.2%), no change was observed in extrapulmonary events.

conclusionsDeaths and ICU hospitalizations were significantly reduced during the second epidemic wave.

Indexed as

COVID-19HumansInpatientsIntensive Care UnitsRetrospective StudiesSARS-CoV-2COVID-19COVID wavesExtrapulmonary complicationsOutcomeSARS-CoV-2

Identifiers

PMID34634485
PMCPMC8500690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.